Papamarkou Wellner Asset Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Papamarkou Wellner Asset Management Inc.
- $162 Billion
- Q3 2025
A detailed history of Papamarkou Wellner Asset Management Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Papamarkou Wellner Asset Management Inc. holds 365 shares of REGN stock, worth $253,127. This represents 0.13% of its overall portfolio holdings.
Number of Shares
365Holding current value
$253,127% of portfolio
0.13%Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,466Shares Held
86.4MCall Options Held
2.42MPut Options Held
1.64M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...